Oman vs Panama: Estimated antiretroviral therapy coverage among people living with HIV
Oman
68.0%
in 2025
Panama
67.0%
in 2025
Oman rank
90th
Panama rank
92nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Oman
- Panama
How they compare
Oman currently reports 68.0% against 67.0% in Panama, a difference of 1.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was Oman ahead.
Oman ranks 90th and Panama ranks 92nd of 143 countries.
Across the 3 decades both report, Oman averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Oman | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.0% | 15.3% | 2.7% | Oman |
| 2010s | 37.8% | 41.9% | 4.1% | Panama |
| 2020s | 61.5% | 62.5% | 1.0% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Oman or Panama?
- Oman, at 68.0% against 67.0% in Panama as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Oman and Panama?
- 1.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Panama?
- 26 years are reported by both, from 2000 to 2025.
- How do Oman and Panama rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Oman ranks 90th and Panama ranks 92nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.